These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19228724)

  • 21. Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma.
    Lo PH; Tanikawa C; Katagiri T; Nakamura Y; Matsuda K
    Oncol Rep; 2015 Jan; 33(1):267-73. PubMed ID: 25370079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cells.
    Rivenbark AG; Jones WD; Risher JD; Coleman WB
    Epigenetics; 2006; 1(1):32-44. PubMed ID: 17998816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine.
    Hayashi M; Bernert H; Kagohara LT; Maldonado L; Brait M; Schoenberg M; Bivalacqua T; Netto GJ; Koch W; Sidransky D; Hoque MO
    Oncotarget; 2014 May; 5(10):3350-61. PubMed ID: 24830820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.
    Overmeer RM; Henken FE; Bierkens M; Wilting SM; Timmerman I; Meijer CJ; Snijders PJ; Steenbergen RD
    J Pathol; 2009 Nov; 219(3):327-36. PubMed ID: 19662663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray.
    Yamashita S; Tsujino Y; Moriguchi K; Tatematsu M; Ushijima T
    Cancer Sci; 2006 Jan; 97(1):64-71. PubMed ID: 16367923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse.
    Noetzel E; Rose M; Sevinc E; Hilgers RD; Hartmann A; Naami A; Knüchel R; Dahl E
    Oncogene; 2010 Aug; 29(34):4814-25. PubMed ID: 20543860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative epigenomics of human and mouse mammary tumors.
    Demircan B; Dyer LM; Gerace M; Lobenhofer EK; Robertson KD; Brown KD
    Genes Chromosomes Cancer; 2009 Jan; 48(1):83-97. PubMed ID: 18836996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic silencing of LRRC3B in colorectal cancer.
    Tian XQ; Zhang Y; Sun D; Zhao S; Xiong H; Fang J
    Scand J Gastroenterol; 2009; 44(1):79-84. PubMed ID: 18815942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.
    Yue W; Dacic S; Sun Q; Landreneau R; Guo M; Zhou W; Siegfried JM; Yu J; Zhang L
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4336-44. PubMed ID: 17671114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    World J Gastroenterol; 2007 Dec; 13(46):6166-71. PubMed ID: 18069755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer.
    Kim MS; Yamashita K; Baek JH; Park HL; Carvalho AL; Osada M; Hoque MO; Upadhyay S; Mori M; Moon C; Sidransky D
    Cancer Res; 2006 Apr; 66(7):3409-18. PubMed ID: 16585162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-lymphocyte maturation-associated protein gene as a candidate metastasis suppressor for head and neck squamous cell carcinomas.
    Beder LB; Gunduz M; Hotomi M; Fujihara K; Shimada J; Tamura S; Gunduz E; Fukushima K; Yaykasli K; Grenman R; Shimizu K; Yamanaka N
    Cancer Sci; 2009 May; 100(5):873-80. PubMed ID: 19445022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
    Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
    J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel target genes by an epigenetic reactivation screen of renal cancer.
    Ibanez de Caceres I; Dulaimi E; Hoffman AM; Al-Saleem T; Uzzo RG; Cairns P
    Cancer Res; 2006 May; 66(10):5021-8. PubMed ID: 16707423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic silencing of RNF144A expression in breast cancer cells through promoter hypermethylation and MBD4.
    Zhang Y; Yang YL; Zhang FL; Liao XH; Shao ZM; Li DQ
    Cancer Med; 2018 Apr; 7(4):1317-1325. PubMed ID: 29473320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
    Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent epigenetic inactivation of cystatin M in breast carcinoma.
    Schagdarsurengin U; Pfeifer GP; Dammann R
    Oncogene; 2007 May; 26(21):3089-94. PubMed ID: 17099723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.
    Kajiura K; Masuda K; Naruto T; Kohmoto T; Watabnabe M; Tsuboi M; Takizawa H; Kondo K; Tangoku A; Imoto I
    Oncotarget; 2017 Jan; 8(2):2890-2905. PubMed ID: 27926516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
    Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
    Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.